BlackRock pulls out of rescue bid for Italian bank Carige
May 9, 2019
Kraft Heinz launches sale of baby food unit: sources
May 9, 2019

Novartis buys dry eye drug from Takeda for up to $5.3 billion

Novartis is buying dry-eye drug Xiidra from Takeda Pharmaceutical Co for up to $5.3 billion as the Swiss drugmaker refreshes its ophthalmic medicines portfolio with a potential blockbuster.

Powered by WPeMatico